| Literature DB >> 27553443 |
Magdalena F Uerlich1, Volkan Yumuk, Nick Finer, Arnaud Basdevant, Tommy L S Visscher.
Abstract
OBJECTIVE: This study aims at assessing the status of obesity management in the European region and identifying future goals and objectives of professionals working in the field of obesity.Entities:
Mesh:
Year: 2016 PMID: 27553443 PMCID: PMC5644860 DOI: 10.1159/000445192
Source DB: PubMed Journal: Obes Facts ISSN: 1662-4025 Impact factor: 3.942
Number of participants per country
| Countries | Number of participants |
|---|---|
| Denmark, Finland, Georgia, Germany, Greece, Hungary, Poland, Slovakia, Spain, Turkey | 1 |
|
| |
| Croatia, Iceland, Sweden | 2 |
|
| |
| Belgium, Israel, Norway, the Netherlands, UK | 3 |
|
| |
| Serbia | 4 |
|
| |
| Czech Republic, Italy | 5 |
|
| |
| France | 7 |
|
| |
| Ireland | 21 |
Extent of guidelines used in practice
| Country | Participants per country | Mean of the answers to the question ‘To what extent are guidelines being used in practice?’ |
|---|---|---|
| Belgium | 3 | 5 |
| Croatia | 2 | 6 |
| Czech Republic | 5 | 6.8 |
| Denmark | 1 | 4 |
| Finland | 1 | 4 |
| France | 7 | 5.4 |
| Georgia | 1 | 5 |
| Germany | 1 | 3 |
| Greece | 1 | 5 |
| Hungary | 1 | 7 |
| Iceland | 2 | 5 |
| Ireland | 21 | 3.8 |
| Israel | 3 | 7 |
| Italy | 5 | 5 |
| Norway | 3 | 5.3 |
| Poland | 1 | 8 |
| Serbia | 4 | 5.8 |
| Slovakia | 1 | 2 |
| Spain | 1 | 5 |
| Sweden | 3 | 5.3 |
| The Netherlands | 3 | 3.7 |
| Turkey | 1 | 4 |
| UK | 3 | 4.7 |
aThe mean of the answers per country, only serve as an indication and should be considered with caution as within-country variation was noticed. Score 1 denotes, guidelines are not used at all in daily practice. Score 6 denotes, guidelines are used to a somewhat high extend in daily practice.
Involvement of experts in the development of national guidelines by country
| General Practitioners | Clinicians | Nurses | Dietitians | Health Organizations | Ministry of Health | Patients | Insurance Companies | Physical activity experts | Psychologists | |
|---|---|---|---|---|---|---|---|---|---|---|
| Belgium | x | x | x | x | x | |||||
| Croatia | x | |||||||||
| Czech Republic | x | x | x | x | x | |||||
| Denmark | x | x | x | x | x | |||||
| Finland | x | x | x | x | ||||||
| France | x | x | x | x | x | x | x | x | x | |
| Georgia | x | x | x | x | ||||||
| Germany | x | x | x | x | x | x | ||||
| Greece | n.a. | |||||||||
| Hungary | x | |||||||||
| Iceland | n.a. | |||||||||
| Ireland | x | x | x | |||||||
| Israel | x | x | ||||||||
| Italy | x | |||||||||
| Norway | x | x | x | x | x | x | x | |||
| Poland | x | x | x | x | x | x | ||||
| Serbia | x | x | x | |||||||
| Slovakia | n.a. | |||||||||
| Spain | x | |||||||||
| Sweden | Indications reached not above 60% of the national participants | |||||||||
| The Netherlands | x | x | x | x | x | x | x | x | ||
| Turkey | x | x | x | x | x | |||||
| UK | x | x | x | x | x | x | x | x | x | |
n.a. = Not available.
aThe professional was indicated to be part of the development of national guidelines in a specific country if 60% or more of the participants indicated that professional to be part of the development.
bFrom Sweden, one of the three participants provided information on the expertise involved in the development of their national guideline.